Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-17
2006-10-17
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S013400, C514S314000, 56, 56, 56
Reexamination Certificate
active
07122560
ABSTRACT:
The present invention provides compounds of Formula (I):or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein the variables A, B, R1, R2, U, X, Y, Z, Ua, Xa, Ya, and Zaare defined are as defined herein, which are useful as inhibitors of matrix metalloproteinases (MMP), and/or TNF-α converting enzyme (TACE), or a combination thereof.
REFERENCES:
patent: 6495548 (2002-12-01), Duan
patent: 6825215 (2004-11-01), Chen et al.
patent: WO 97/32846 (1997-09-01), None
Bristol--Myers Squibb Company
Desai Rita
Sun Jing G.
LandOfFree
Lactam derivatives as inhibitors of matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactam derivatives as inhibitors of matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam derivatives as inhibitors of matrix... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3645813